Parkinson’s – Autologous Stem Cell Therapy Results (N=50) – XCell-Center

Parkinson’s – Autologous Stem Cell Therapy Results (N=50)

Introduction 

Parkinson’s disease (also known as Parkinson disease or PD) is a degenerative disorder of the central nervous system that often impairs the sufferer’s motor skills, speech, and other functions.[1]

Parkinson’s disease belongs to a group of conditions called movement disorders. It is characterized by muscle rigidity, tremor, a slowing of physical movement (bradykinesia) and a loss of physical movement (akinesia) in extreme cases. The primary symptoms are the results of decreased stimulation of the motor cortex by the basal ganglia, normally caused by the insufficient formation and action of dopamine, which is produced in the dopaminergic neurons of the brain. Secondary symptoms may include high level cognitive dysfunction and subtle language problems. PD is both chronic and progressive.

Method

50 patients with Parkinson’s disease were treated with Autologous stem cells by the XCell-Center. Injection of the Stem Cells was performed by Lumbar Puncture. 200 ml of Bone Marrow was extracted out of the Iliaca crest and was concentrated for transplantation using gradient centrifugation. After treatment, the patients were evaluated using a post treatment survey. The results are presented below.

Results

Nearly 60% of patients treated reported an improvement in their condition after treatment.

Parkinson Overall Results Mar 29 10 

The average patient age was 65 years old.  Patients as young as 38 years old and as old as 85 years old were treated.  80% were female.  The average follow-up time was 7 months after treatment.  Most patients experienced improvements after a couple of months.

 Parkinson Age Distribution

Approximately 60% of improved patients reported better speech, handwriting and ability to use utensils.  About 1/3 experienced improved ability to swallow and control saliva (drooling).

Parkinson Daily Living Improvements 1

3 out of 4 patients who improved experienced decreased rigidity and a little more than half reported decreased tremors.  Over 85% reported improved walking ability.  While greater than 80% experienced improved gait.

 Parkinson Motor Function Improvements

60% of patients who reported improvements had them confirmed by their personal physician. 

 Parkinson Doctor Confirmations

Approximately 40% of all improved patients reduced or eliminated their use of Parkinson’s medications.

Parkinson Medication Change B

In a Patient’s Own Words

Johannes Wolf – 72 years old
“…I no longer have any pain and I am completely drug free…”

Aubra Phillips – 59 years old
“…After the stem cell treatment I would no longer freeze…”

Ted Ebertsch – 66 years old
“…My neurologist saw me during this time and confirmed that I looked like I was doing very well…”

Jon Andresen – 71 years old
“…Now, I am walking like I was before I had Parkinson’s…”

Start the online Medical Treatment Evaluation

References:

Jankovic J (April 2008). “Parkinson’s disease: clinical features and diagnosis”. J. Neurol. Neurosurg. Psychiatr. 79 (4): 368-76


  This content has been Digiproved

Advertisements
This entry was posted in Healthcare. Bookmark the permalink.

3 Responses to Parkinson’s – Autologous Stem Cell Therapy Results (N=50) – XCell-Center

  1. Pingback: Parky Headlines, April 23, 2010 | My Parkinson's Diary

  2. Pingback: I’ll MAKE Me Some PD Awareness! | My Parkinson's Diary

  3. Pingback: Parky Headlines, April 24, 2010 | My Parkinson's Diary

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s